BACTERIOSTATIC WATER LABORATORY DILUENT

What the reference labels say. Hospira's US prescribing information for its bacteriostatic water, published on the National Library of Medicine's DailyMed, describes a sterile, nonpyrogenic preparation with benzyl alcohol at 0.9% (9 mg/mL) or 1.1% (11 mg/mL) as the bacteriostatic preservative, packed in a multi-use container that allows repeated withdrawals.¹ The preservative holds back bacterial growth; it cannot make an already-contaminated solution sterile, which is why the label still requires aseptic technique for every entry.¹

Compared with sterile water. Hospira's sterile water label describes a product with no bacteriostat, antimicrobial agent or added buffer, packed in single-use containers, with whatever is left after opening to be discarded.² If a peptide is dissolved once, aliquoted and frozen immediately, the vial is never re-entered and the preservative offers nothing extra. Safe repeat entry into the same vial is the whole point of adding it.

Benzyl alcohol is not inert. The bacteriostatic water label warns that benzyl alcohol "has been associated with toxicity in neonates", and 1982 reports tied it to the neonatal "gasping syndrome".^1,3 The label adds that some solutes may be incompatible with it.¹ In formulation work on a recombinant protein, dissolving the freeze-dried product in 0.9% benzyl alcohol gave more aggregation than dissolving it in water.⁴ In cultured cells, benzyl alcohol fluidises membranes and caused a reversible break-up of the Golgi apparatus.⁵ These findings involve a protein and cell systems rather than short peptides, but they are why compatibility is tested, not assumed: run a vehicle control with the same benzyl alcohol concentration in cell-based work, or switch to sterile water or buffer if the assay is sensitive.

Choosing a diluent starts with the peptide's charge and hydrophobicity; our guide to bacteriostatic water and reconstituting peptides covers that in detail, and how to read a peptide COA explains where solubility information may be stated.

The labels cited on this page are US prescribing information for two Hospira products, published on DailyMed.^1,2 They describe those products, not the vial sold here. Titan Peptides supplies its 3 mL bacteriostatic water as a laboratory reagent, a diluent for reconstituting lyophilised research peptides. This page does not state the vial's benzyl alcohol concentration: read it from the vial label rather than assuming the 0.9% common on US labels, and check its expiry date. The Hospira label also advises against keeping reconstituted solutions unless the manufacturer of the dissolved product says otherwise.¹ The research-grade peptides it is used with are not approved medicines; see our guide to Australian research peptide law.

Before each entry into an opened multi-use vial, wipe the septum with 70% alcohol and let it dry, and work with sterile single-use consumables in a biological safety cabinet or laminar-flow bench. Look at the liquid first: the US label says not to use it unless the solution is clear and the seal intact. Note the date the vial was first opened, and store it as its own label directs. The preservative slows growth but cannot reverse contamination introduced at entry. A peptide solution made with it follows the peptide's storage guidance, not the diluent's, so aliquot and freeze it. More on storing lyophilised and reconstituted peptides and choosing a diluent for reconstitution.